These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19661303)

  • 1. Mifepristone treatment improves length and quality of survival of mice with spontaneous leukemia.
    Check JH; Sansoucie L; Chern J; Amadi N; Katz Y
    Anticancer Res; 2009 Aug; 29(8):2977-80. PubMed ID: 19661303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.
    Check JH; Sansoucie L; Chern J; Dix E
    Anticancer Res; 2010 Jan; 30(1):119-22. PubMed ID: 20150625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.
    Check JH; Dix E; Cohen R; Check D; Wilson C
    Anticancer Res; 2010 Feb; 30(2):623-8. PubMed ID: 20332480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.
    Check JH; Dix E; Wilson C; Check D
    Anticancer Res; 2010 Dec; 30(12):4921-3. PubMed ID: 21187471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein.
    Check JH; Dix E; Sansoucie L
    Med Hypotheses; 2009 Jan; 72(1):87-90. PubMed ID: 18842348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity.
    Check JH; Sansoucie L; Chern J; Amadi N; Srivastava M; Larece K
    Clin Exp Obstet Gynecol; 2007; 34(4):207-11. PubMed ID: 18225679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report.
    Check JH; Dix E; Sansoucie L; Check D
    Anticancer Res; 2009 May; 29(5):1611-3. PubMed ID: 19443374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
    Ramondetta LM; Johnson AJ; Sun CC; Atkinson N; Smith JA; Jung MS; Broaddus R; Iyer RB; Burke T
    Cancer; 2009 May; 115(9):1867-74. PubMed ID: 19241422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
    Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
    Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone causing complete remission of rapidly advancing leukemia with measurement of progesterone-induced blocking factor.
    Check JH; Check D; Cohen R; Sarumi M
    Anticancer Res; 2014 May; 34(5):2413-6. PubMed ID: 24778052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the glucocorticoid antagonist, mifepristone, on the consequences of withdrawal from long term alcohol consumption.
    Jacquot C; Croft AP; Prendergast MA; Mulholland P; Shaw SG; Little HJ
    Alcohol Clin Exp Res; 2008 Dec; 32(12):2107-16. PubMed ID: 18828802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers - A Review.
    Check JH; Check D
    Anticancer Res; 2019 Jul; 39(7):3365-3372. PubMed ID: 31262857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progesterone receptor antagonist mifepristone does not lower serum progesterone induced blocking factor (PIBF) in the presence of progesterone.
    Check JH; DiAntonio G; DiAntonio A; Duroseau M
    Clin Exp Obstet Gynecol; 2016; 43(2):189-91. PubMed ID: 27132407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life.
    Check JH; Check D; Srivastava MD; Poretta T; Aikins JK
    Anticancer Res; 2020 Dec; 40(12):6997-7001. PubMed ID: 33288594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
    Check JH; Check DL
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that Mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV.
    Check JH; Wilson C; Cohen R; Sarumi M
    Anticancer Res; 2014 May; 34(5):2385-8. PubMed ID: 24778047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor antagonists.
    Spitz IM
    Curr Opin Investig Drugs; 2006 Oct; 7(10):882-90. PubMed ID: 17086932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel phosphorus-containing 17beta-side chain mifepristone analogues as progesterone receptor antagonists.
    Jiang W; Allan G; Chen X; Fiordeliso JJ; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z
    Steroids; 2006 Nov; 71(11-12):949-54. PubMed ID: 16934845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone does not induce cervical softening in non-pregnant women.
    Ben-Chetrit A; Eldar-Geva T; Lindenberg T; Farhat M; Shimonovitz S; Zacut D; Gelber H; Sitruk-Ware R; Spitz IM
    Hum Reprod; 2004 Oct; 19(10):2372-6. PubMed ID: 15271871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor.
    Check JH; Check D
    Anticancer Res; 2021 Dec; 41(12):5873-5880. PubMed ID: 34848442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.